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Malakoplakia is a rare, granulomatous condition most commonly found in the genitourinary tract. It can
present in a myriad of ways depending on the organ involved, thus presenting a huge diagnostic chal-
lenge. We present 4 patients with genitourinary malakoplakia, who manifested with recurrent urinary
tract infection (UTI) and hematuria in all except one, who presented with hydronephrosis secondary to a
large pelvic mass. We discuss the need for a high index of suspicion and careful scrutiny of histology to
order to avoid misdiagnosis as simple long term antibiotics are an effective treatment in all but those
with large pelvic masses.
 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
Malakoplakia is deﬁned histopathologically by MichaeliseGut-
mann bodies andwhilst the etiology is uncertain, it is believed to be
associated with defective macrophage function. It can occur in
almost any part of the body but is most commonly found in the
genitourinary tract. Because it is so rare and can present in a
number of different ways, malakoplakia poses a difﬁcult diagnostic
challenge. We report four cases of malakoplakia identiﬁed from the
uro-pathology database at Queen Elizabeth Hospital Birmingham
(QEHB) over the last 10 yrs.Case histories
All patients were women with a mean age of 55 years (range:
49e65 yrs) with all suffering from asthma, menstrual irregularities
and lower urinary tract symptoms (LUTS). The presenting symp-
tomatology was recurrent UTI and hematuria in all except one who
presented with upper tract obstruction secondary to a large pelvic
inﬂammatory mass. Upper tract investigations were normal in the
three patients with recurrent UTI. Cystoscopy and bladder biopsies
were undertaken which on histological assessment showed that
the lamina propriae was inﬁltrated by foamy macrophages con-
taining MichaeliseGutmann bodies. These patients were treated
with low dose prophylactic antibiotics with symptomatic
improvement and no further UTIs. Mean follow up was 50 months, Birmingham B29 4LN, UK.
Inc. This is an open access article u(range: 25e108 months). One of the patients has stopped her an-
tibiotics after one year with no recurrence of symptoms. The lesions
remained static on ﬂexible cystoscopy after treatment.
The patient with pelvic malakoplakia is a 49 yr old lady with
Type II diabetes, obesity, asthma and congestive cardiac failure. She
initially presented with an incidental ﬁnding of deranged renal
function and underwent imaging with computerized tomography
(CT) and magnetic resonance imaging (MRI) as shown in Fig. 1 and
Fig. 2. These revealed abnormal soft tissue at the aortic bifurcation
and pre-sacral area forming a dense ﬁbrotic inﬂammatory reaction
involving a large left ovarian cyst, the uterus, bladder, small bowel
and both ureters causing bilateral hydronephrosis. The initial
thought was that of intra-abdominal malignancy or retroperitoneal
ﬁbrosis but further histology was compatible with a diagnosis of
malakoplakia. The patient was due to have laparotomy for removal
of ovarian mass and ureterolysis, with pre-operative bilateral
ureteric stenting, but was deemed unﬁt at pre-operative assess-
ment. The patient received retrograde ureteric stents meanwhile,
leading to an improvement in renal function. The patient has
received long term antibiotics which included a combination of
rifampicin, ciproﬂoxacin and amoxicillin, with repeat CT showing a
minor degree of shrinkage in size of the pelvic mass and some
symptomatic beneﬁt.
Discussion
Malakoplakia was ﬁrst reported by Michaelis and Gutmann1 in
1902, but it was Professor von Hansemann who ﬁrst identiﬁed the
condition a year earlier. It is deﬁned histologically by von Hanse-
mann histiocytes and MichaeliseGutmann bodies.2 Von Hanse-
mann cells are ovoid histiocytes which contain intracytoplasmicnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Figure 1. MRI pelvis of patient with pelvic malakoplakia showing large pelvic mass.
Figure 3. 400 High power hematoxylin and eosin (H&E) stain showing sheets of
foamy macrophages and MichaeliseGutmann (MG) bodies.
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characteristics, being gram-negative and positive for alizarin red
and von Kossa stain (calcium), Perls’ stain and Prussian blue (iron),
and Periodic Acid-Schiff stain. Fig. 3 shows histology taken from
one of the patients demonstrating H&E staining characteristics of
MichaeliseGutmann bodies. Whilst etiology is unclear, it is
believed that malakoplakia occurs due to defective bacterial
digestion, leading to calcium and iron accumulation on the residual
bacterial glycolipid. This is found within the pathognomonic
MichaeliseGutmann bodies.
The genitourinary tract is most commonly involved area in pa-
tients with malakoplakia, mostly affecting the bladder, prostate,
ureter, kidney, female genital tract and retroperitoneal tissue. In our
series the most common site was the bladder (three patients) and
the fourth patient had a large pelvic inﬂammatory mass. The pre-
sentation of malakoplakia of the genitourinary tract can be very
varied depending on the area involved and is often not diagnosed
until symptoms have persisted for quite some time.
Malakoplakia of the bladder usually presents with recurrent
UTIs, lower urinary tract symptoms or hematuria.3 Typically
Escherichia coli is grown in urine culture and upon ﬂexible cystos-
copy, yellow brown soft plaques with a central umbilication are the
most frequent ﬁnding. Malakoplakia of the bladder has also been
found in associationwith bladder tumors3 with or without a history
of infection. This makes the accurate identiﬁcation of malakoplakia
especially important in the context of a suspicion of malignancy.Figure 2. MRI pelvis of patient with pelvic malakoplakia showing hydronephrosis of
right kidney.Malakoplakia arising from retroperitoneal organs has the po-
tential to spread throughout the retroperitoneum resulting in
extensive pelvic malakoplakia. This most commonly occurs in
malakoplakia of the bladder and the female genital tract. The
mechanism of pelvic mass formation is unknown. It is presumably
due to aggressive immune reaction to a urinary tract pathogen
which causes scar tissue around the urogenital organs which then
involves adjacent viscera forming a mass. The consequences
depend on the organs involved but can cause renal failure if both
ureters are compressed such as the patient in our series with
extensive pelvic malakoplakia. Extensive pelvic malakoplakia can
often be mistaken for invasive cancer4 on CT and so careful scrutiny
of biopsies are vital.
Treatment of malakoplakia is mostly medical with surgical
intervention sometimes being necessary. There are no widely
established guidelines for the medical treatment of malakoplakia
but most approaches involve antibiotics5 which work intracellu-
larly such as quinolones (mainstay of treatment), trimethoprim and
rifampicin to aid the defective phagolysosomalmechanism found in
malakoplakia. These can be used long-term at low doses to prevent
recurrence. Moreover, as immunosuppression has been implicated
in malakoplakia, patients on immunosuppressants may need to
discontinue them depending on the risk to beneﬁt ratio. It is
interesting to note that all 4 of our patients withmalakoplakia had a
history of asthma. Whilst this may be a coincidence, this could
perhaps be tentatively explained by the fact that asthma is a hy-
persensitivity immune disorder and immune deﬁciencies have
been associated with malakoplakia.
Surgical treatment may be necessary depending on the organ(s)
affected. Vesical malakoplakia may occasionally require transure-
thral resection if the lesion is large or obstructing the ureters, in
addition to nephrostomy/ureteric stenting. Patients with extensive
pelvic malakoplakia will often need large, complex abdominal
surgery especially if the bowel is involved.
Conclusion
Malakoplakia of the urogenital tract is a rare condition which
requires careful histological scrutiny to diagnose correctly. We
illustrate with these 4 cases that most patients, once accurately
diagnosed, can be successfully treated with long term low dose
antibiotics. However, patients with large pelvic masses may require
further surgical intervention.
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